MIRAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 12 Aug 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90879030
- Mark type
- Stylized text
- Filed
- 12 Aug 2021
- Published for opposition
- 12 Jul 2022
- Attorney of record
- CHRISTINA M. LICURSI
Goods and services
- Class 001 — Chemicals: proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products
- Class 005 — Pharmaceuticals: protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, artificially produced peptides and proteins for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, and fungal diseases and disorders; therapeutic pharmaceuticals, namely, artificially produced peptides and proteins for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders, none of the foregoing pertaining to Parkinson's Disease or Restless Legs Syndrome
- Class 042 — Scientific and technological services: scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products
Owner
- Flagship Labs 83, Inc., Cambridge, MA, US
- Flagship Labs 83, Inc., Cambridge, MA, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 4 GRANTED
- 31 Mar 2026 — SOU EXTENSION 4 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2025 — SOU EXTENSION 3 GRANTED
- 21 Oct 2025 — SOU EXTENSION 3 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2025 — SOU EXTENSION 2 GRANTED
- 16 Apr 2025 — SOU EXTENSION 2 FILED
- 16 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2024 — SOU EXTENSION 1 GRANTED
- 21 Oct 2024 — SOU EXTENSION 1 FILED